stockrowTuHURA Biosciences, Inc. (HURA) vs Outlook Therapeutics, Inc. (OTLK)
- TuHURA Biosciences, Inc. HURA 1.63 +1.24%
- Outlook Therapeutics, Inc. OTLK 0.43 −2.27%
TuHURA Biosciences, Inc. and Outlook Therapeutics, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and Outlook Therapeutics, Inc. are of similar size ($106.9M and $102.6M). Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs −74.2%). Across the 13 metrics below, Outlook Therapeutics, Inc. leads on 10 and TuHURA Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | HURA | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 195.62% | 68.51% |
| Operating margin | 0.00% | 4,781.76% | 0.00% |
| Net margin | 0.00% | 5,253.40% | 0.00% |
| Free cash flow margin | 0.00% | 4,826.38% | 0.00% |
| Return on equity | (163.84%) | 256.92% | (51.96%) |
| Return on assets | (92.31%) | (251.66%) | (46.06%) |
| Return on invested capital | (74.20%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack